Ekso Bionics Holdings Statistics
Total Valuation
EKSO has a market cap or net worth of $8.31 million. The enterprise value is $5.91 million.
Important Dates
The next estimated earnings date is Monday, July 28, 2025, after market close.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EKSO has 1.94 million shares outstanding. The number of shares has increased by 48.71% in one year.
| Current Share Class | 1.94M |
| Shares Outstanding | 1.94M |
| Shares Change (YoY) | +48.71% |
| Shares Change (QoQ) | +3.06% |
| Owned by Insiders (%) | 3.99% |
| Owned by Institutions (%) | 6.85% |
| Float | 1.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| Forward PS | 0.43 |
| PB Ratio | 0.64 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.35, with a Debt / Equity ratio of 0.44.
| Current Ratio | 2.35 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.85 |
Financial Efficiency
Return on equity (ROE) is -80.71% and return on invested capital (ROIC) is -33.37%.
| Return on Equity (ROE) | -80.71% |
| Return on Assets (ROA) | -23.25% |
| Return on Invested Capital (ROIC) | -33.37% |
| Return on Capital Employed (ROCE) | -55.79% |
| Revenue Per Employee | $265,818 |
| Profits Per Employee | -$163,515 |
| Employee Count | 66 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.74% in the last 52 weeks. The beta is 0.89, so EKSO's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -72.74% |
| 50-Day Moving Average | 5.80 |
| 200-Day Moving Average | 10.26 |
| Relative Strength Index (RSI) | 35.28 |
| Average Volume (20 Days) | 439,881 |
Short Selling Information
The latest short interest is 203,418, so 10.51% of the outstanding shares have been sold short.
| Short Interest | 203,418 |
| Short Previous Month | 326,207 |
| Short % of Shares Out | 10.51% |
| Short % of Float | 12.26% |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, EKSO had revenue of $17.54 million and -$10.79 million in losses. Loss per share was -$7.31.
| Revenue | 17.54M |
| Gross Profit | 9.37M |
| Operating Income | -10.46M |
| Pretax Income | -12.42M |
| Net Income | -10.79M |
| EBITDA | -8.88M |
| EBIT | -10.46M |
| Loss Per Share | -$7.31 |
Full Income StatementBalance Sheet
The company has $8.05 million in cash and $5.62 million in debt, giving a net cash position of $2.44 million or $1.26 per share.
| Cash & Cash Equivalents | 8.05M |
| Total Debt | 5.62M |
| Net Cash | 2.44M |
| Net Cash Per Share | $1.26 |
| Equity (Book Value) | 12.69M |
| Book Value Per Share | 6.75 |
| Working Capital | 11.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.35 million and capital expenditures -$39,000, giving a free cash flow of -$8.38 million.
| Operating Cash Flow | -8.35M |
| Capital Expenditures | -39,000 |
| Free Cash Flow | -8.38M |
| FCF Per Share | -$4.33 |
Full Cash Flow StatementMargins
Gross margin is 53.39%, with operating and profit margins of -59.64% and -61.51%.
| Gross Margin | 53.39% |
| Operating Margin | -59.64% |
| Pretax Margin | -61.51% |
| Profit Margin | -61.51% |
| EBITDA Margin | -50.64% |
| EBIT Margin | -59.64% |
| FCF Margin | n/a |
Dividends & Yields
EKSO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -48.71% |
| Shareholder Yield | -48.71% |
| Earnings Yield | -129.32% |
| FCF Yield | -100.47% |
Analyst Forecast
The average price target for EKSO is $37.50, which is 774.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.50 |
| Price Target Difference | 774.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
EKSO has an Altman Z-Score of -12.34 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.34 |
| Piotroski F-Score | 4 |